| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 270 | $1,110 | $300.3K |
| A9587 | Gallium ga-68, dotatate, diagnostic, 0.1 millicurie | 1,510 | $50 | $74.2K |
| A9800 | Gallium ga-68 gozetotide, diagnostic, (locametz), 1 millicurie | 70 | $740 | $54.5K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 250 | $190 | $47K |
| 78816 | The patient is injected with a radiopharmaceutical tracer called FDG (fluoro–deoxyglucose, a radioactive substance containing glucose) about one hour before the imaging is scheduled to begin. The… | 10 | $1,140 | $13.7K |
| 78830 | The provider uses a nuclear imaging test called SPECT with concurrent CT imaging to localize a tumor, inflammatory process, or radioactive tracer distribution. Vascular flow and blood pool imaging… | 70 | $50 | $3.6K |
| 78451 | In this procedure, the provider performs a single SPECT study of the heart to determine the areas of deficient blood flow. The goal of the procedure is to determine areas that have deficient blood… | 40 | $50 | $2K |
| 79101 | In this procedure, the provider injects a radiopharmaceutical substance into the venous blood stream to treat the patient’s condition. | 20 | $70 | $1.6K |
| 78195 | In this procedure, the provider uses a gamma–emitting radioactive tracer to diagnose and localize diseases of the lymphatics and lymph nodes. | 30 | $40 | $1.4K |
| 78452 | In this procedure, the provider performs multiple SPECT studies of the heart to determine the areas of deficient blood flow. The goal of the procedure is to determine areas that have deficient blood… | 20 | $60 | $1.2K |